Axel Bolte Inozyme Pharma, Inc. (INZY) insider trading activity

INZY Quotes by TradingView

Axel Bolte is Director of Inozyme Pharma, Inc.. Currently has a direct ownership of 266,696 shares of INZY, which is worth approximately $1.29 Million. The most recent transaction as insider was on Mar 31, 2023, when has been sold 4,806 shares (Common Stock) at a price of $2.21 per share, resulting in proceeds of $10,621. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 267K
0% 3M change
0% 12M change
Total Value Held $1.29 Million

Axel Bolte Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 31 2023
BUY
Grant, award, or other acquisition
$10,621 $2.21 p/Share
4,806 Added 1.77%
266,696 Common Stock
Sep 30 2022
BUY
Grant, award, or other acquisition
$7,558 $2.28 p/Share
3,315 Added 1.25%
261,890 Common Stock
Apr 19 2022
BUY
Open market or private purchase
$249,998 $3.69 p/Share
67,750 Added 20.76%
258,575 Common Stock
Jun 24 2021
SELL
Open market or private sale
-
66,788 Reduced 25.93%
190,825 Common Stock
Jun 24 2021
BUY
Exercise of conversion of derivative security
$65,452 $0.98 p/Share
66,788 Added 20.59%
257,613 Common Stock

Also insider at

ISEE
IVERIC bio, Inc. Healthcare
Director
AB

Axel Bolte

Director
Parsippany, NJ

Track Institutional and Insider Activities on INZY

Follow Inozyme Pharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INZY shares.

Notify only if

Insider Trading

Get notified when an Inozyme Pharma, Inc. insider buys or sells INZY shares.

Notify only if

News

Receive news related to Inozyme Pharma, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on INZY